Holding(s) in Company (9352X)
22 Fevereiro 2012 - 2:46PM
UK Regulatory
TIDMAGI
RNS Number : 9352X
AGI Therapeutics plc
22 February 2012
AGI Therapeutics plc ('AGI')
Holding in Company
AGI was notified on 22 February 2012 that as of 16 February 2012
Aravis Therapeutics Limited has a shareholding of 60,784,191
ordinary shares of EUR0.10 each representing 90.17 per cent of
AGI's entire issued share capital.
Contact Information
AGI Therapeutics
David G. Kelly, Chief Financial Officer Tel: +353 1 449 3254
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUUSNRUVAUUAR
AGI (LSE:AGI)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
AGI (LSE:AGI)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025
Notícias em tempo-real sobre AGI da Bolsa de Valores de Londres bolsa de valores: 0 artigos recentes
Mais Notícias de AGI Therapeutics plc